Across Europe , awareness surrounding copyright as a option for psychiatric conditions is growing . While traditionally viewed primarily as an veterinary agent, its promise in treating depression , particularly treatment-resistant cases, is driving a significant alteration in clinical practice . Despite this, access is complex and differs widely ac